Enhanced alveo pulmonary deposition of nebulized ciclesonide for attenuating airways inflammations: a strategy to overcome metered dose inhaler drawbacks

Enhanced alveo pulmonary deposition of nebulized ciclesonide for attenuating airways inflammations: a strategy to overcome metered dose inhaler drawbacks

Ciclesonide (CIC), an inhaled corticosteroid for bronchial asthma is currently available as metered dose inhaler (CIC–MDI) which possesses a major challenge in the management of the elderly, critically ill patients and children. In this work, nebulized CIC nano-structure lipid particles (CIC-NLPs) w...

Full description

Bibliographic Details
Main Authors: Hanan M. El-Laithy, Amal Youssef, Shereen S. El-Husseney, Nesrine S. El Sayed, Ahmed Maher
Format: Article
Language:English
Published: Taylor & Francis Group 2021-01-01
Series:Drug Delivery
Subjects:
aerosol
bronchial asthma
ciclesonide
nanolipid particles
nebulizer
pulmonary delivery
Online Access:http://dx.doi.org/10.1080/10717544.2021.1905747

Internet

http://dx.doi.org/10.1080/10717544.2021.1905747

Similar Items